Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07174349 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Name: Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery — clinical trial record (NCT07174349)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorMayo Clinic

Started2026-10-01

View on ClinicalTrials.gov ↗

Amendment history

2026-06-25

Study Status v4

Start date2026-04-10→2026-10-01

2026-04-02

Study Status v3

Start date2026-02-01→2026-04-10

2026-01-20

Study Status v2

Primary completion date2027-12-31→2027-01-31

Start date2025-12-01→2026-02-01

2025-11-11

Study Status v1

Start date2025-10-01→2025-12-01

2025-09-12

Original filing

Mayo Clinic

1,015 trials monitored

See 115 trials at risk

The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.

Trial Details

NCT Number	NCT07174349
Lead Sponsor	Mayo Clinic
Conditions	Urinary Retention Postoperative
Enrollment	20 participants
Start Date	2026-10-01
Primary Completion	2027-01-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-29